Basic Information

Reference Number

0000275589

Issuing Organization

University Of Calgary

Solicitation Type

RFP - Request for Proposal (Formal)

Solicitation Number

2024RFP0037

Title

DRUG FORMULATION AND DEVELOPMENT

Source ID

PU.AC.Alta..1083035.C108347

Agreement Types

Canadian Free Trade Agreement (CFTA)

New West Partnership Trade Agreement (NWPTA)

Details

Location

Canada, Alberta, Calgary

Description

The University of Calgary (UCalgary) is inviting qualified, Health Canada, FDA, or equivalent certified GMP (Good Manufacturing Practices) facility Proponent(s) to submit proposals for drug development and manufacturing services to supply D-Cycloserine to be utilized for human subject usage in treating Major Depressive Disorder (the “Method of Use”) for the Mental Health Initiative for Stress and Trauma experimental study use only.

Dates

Publication

2024/08/12 01:39:27 PM MDT

Bid Intent

Not Available

Question Acceptance Deadline

2024/08/26 04:00:00 PM MDT

Questions are submitted online

Yes

Closing Date

2024/09/12 11:00:00 AM MDT

Contact Information

Melissa Innes

403-220-5188

mjinnes@ucalgary.ca

Bid Submission Process

Bid Submission Type

Electronic Bid Submission

Pricing

In attached document

Bid Documents List

Item Name	Description	Mandatory	Limited to 1 file
Bid Documents	Documents defining the proposal	Yes	No
No entries

© MERX - All rights reserved. No part of the information on this Web Site may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of MERX and the Minister of the participating government department (if applicable). MERX, the Minister nor the Contracting Authority will assume responsibility or liability for the accuracy of the information contained in the publication.